ERO1A and lung adenocarcinoma: This finding is consistent with our analysis of data from the Oncomine database, which revealed significantly elevated expression levels of ERO1L in lung adenocarcinoma (LUAD; p <0.001) and in lung squamous cell carcinoma (LUSC; p <0.001).